your partner in preclinical research

MAGenTA

MAGenTA

The aim of this public-private partnership project involves the establishment of experimental models and clinical trials dedicated to urogenital diseases.

 

Scientific partners

 

Magenta scientific partners

 

MAGenTA is an industrial research project formed to accelerate the selection and validation of new and effective treatments for major urogenital diseases with a total budget of 22.5 million euros. This innovative translational research program will pool technical and human resources allocated to the development and characterization of novel and predictive experimental models of urogenital diseases, which will enable validation of the effectiveness of a new generation of therapeutic molecules. After initial validation, the overall approach will be extended to other tissue and pathological models. The project also includes the development of innovative gene transfer tools as well as the development of functional exploration platforms.

The five years project is managed and coordinated by Vectalys and includes three other SMEs (Urosphere, Ixaltis, Genticel and Vectalys) and two academic institutions (L’Institut de la Clinique de la Souris and l’Ecole Nationale Vétérinaire de Toulouse) belonging to two clusters (Alsace BioValley and Cancer-Bio-Santé in Toulouse respectively).

 

Clusters & Business partners

 

Magenta business partners